Integrin β1, myosin light chain kinase and myosin IIA are required for activation of PI3K-AKT signaling following MEK inhibition in metastatic triple negative breast cancer.

在转移性三阴性乳腺癌中，MEK 抑制后，PI3K-AKT 信号通路的激活需要整合素 β1、肌球蛋白轻链激酶和肌球蛋白 IIA